UBS Group
LONA

UBS Group’s LeonaBio Inc LONA Stock Holding History

UBS Group’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8K Sell
196
-1,103
-85% -$10.3K ﹤0.01% 9468
2026
Q1 		$13.4K Sell
1,299
-2,089
-62% -$13.6K ﹤0.01% 8219
2025
Q4 		$25.6K Buy
3,388
+3,244
+2,253% +$14.9K ﹤0.01% 7618
2025
Q3 		$596 Sell
144
-20,204
-99% -$79.3K ﹤0.01% 9611
2025
Q2 		$61.4K Buy
20,348
+12,693
+166% +$35.9K ﹤0.01% 7602
2025
Q1 		$21.8K Sell
7,655
-1,043
-12% -$4.62K ﹤0.01% 8177
2024
Q4 		$51.1K Buy
8,698
+7,515
+635% +$42.4K ﹤0.01% 7278
2024
Q3 		$5.28K Buy
1,183
+1,090
+1,172% +$25.6K ﹤0.01% 8073
2024
Q2 		$2.47K Hold
93
– – ﹤0.01% 8353
2024
Q1 		$2.55K Hold
93
– – ﹤0.01% 7876
2023
Q4 		$2.27K Sell
93
-9,857
-99% -$175K ﹤0.01% 8134
2023
Q3 		$201K Buy
9,950
+7,120
+252% +$182K ﹤0.01% 5380
2023
Q2 		$83.5K Buy
2,830
+481
+20% +$13.7K ﹤0.01% 6152
2023
Q1 		$58.7K Sell
2,349
-7,935
-77% -$256K ﹤0.01% 6324
2022
Q4 		$326K Buy
10,284
+3,772
+58% +$119K ﹤0.01% 5050
2022
Q3 		$193K Buy
6,512
+828
+15% +$28.6K ﹤0.01% 5110
2022
Q2 		$173K Buy
5,684
+52
+0.9% +$4.76K ﹤0.01% 5036
2022
Q1 		$760K Buy
5,632
+4,312
+327% +$455K ﹤0.01% 4359
2021
Q4 		$172K Sell
1,320
-5,549
-81% -$702K ﹤0.01% 5830
2021
Q3 		$644K Buy
6,869
+6,743
+5,352% +$686K ﹤0.01% 4540
2021
Q2 		$13K Buy
126
+56
+80% +$9.78K ﹤0.01% 7769
2021
Q1 		$13K Sell
70
-16,315
-100% -$3.6M ﹤0.01% 7726
2020
Q4 		$5.61M Buy
16,385
+13,888
+556% +$3.28M ﹤0.01% 2337
2020
Q3 		$461K Buy
+2,497
New +$417K ﹤0.01% 4257

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
SSC
Spruce Street Capital New York $510M AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

UBS Group's LONA Position: Q2 2026 in Review

UBS Group reduced its LeonaBio Inc (LONA) stake by 85% in Q2 2026, selling an estimated $10.3K and leaving 196 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #9468.

UBS Group first reported a position in LONA in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.61M in Q4 2020. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • UBS Group held 196 shares of LeonaBio Inc worth $1.8K as of Q2 2026.
  • UBS Group sold 1,103 LeonaBio Inc shares in Q2 2026, an estimated $10.3K.
  • LeonaBio Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9468 holding.
  • UBS Group first reported a position in LeonaBio Inc in Q3 2020 and has held it in 24 quarters since.
  • UBS Group's LeonaBio Inc position peaked at $5.61M in Q4 2020.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.